In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Apovia AG

Latest From Apovia AG

Recent Dealmaking (10/2003)

Summarizing the month in European dealmaking.

Evotec Goes Wholesale

VC firm Oxford Bioscience's deal with Evotec gives its portfolio companies discounted access to the German biotech's screening and chemistry services--but with no obligation.
Europe North America

Dealmaking (06/02)

Summarizing the month in European dealmaking.

Diagnostics as Venture Investments

Will the emergence of new biological targets as a result of genomics and proteomics change venture investors' prejudice against diagnostics? No--or at least not until patented biomarkers can be tied more closely to the cause of the disease and to a therapeutic that treats it.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Evax Technologies GMBH
  • Apovia
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Apovia AG
  • Senior Management
  • Martin Steiner, PhD, CEO
  • Contact Info
  • Apovia AG
    Phone: (49) 89899674
    Fraunstrasse 10
    Martinsried, D-82152